Proton Pump Inhibitors and Gastric Cancer
Concerns have been raised regarding the long-term use of proton pump inhibitors (PPIs) as an important risk factor for gastric cancer in clinical practice. PPIs can cause hypergastrinemia at clinical doses, and hypergastrinemia has been reported to induce malignant neoplasms in the stomach in previo...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Yong Chan Lee
2021-09-01
|
| Series: | The Korean Journal of Helicobacter and Upper Gastrointestinal Research |
| Subjects: | |
| Online Access: | http://www.helicojournal.org/upload/pdf/kjhugr-2021-0010.pdf |